Related Experiment Video
Updated: Oct 28, 2026

Experimental Protocol of a Three-minute, All-out Arm Crank Exercise Test in Spinal-cord Injured and Able-bodied Individuals
Published on: June 8, 2017
The Record Power Output 1-12 Test for Estimating the Anaerobic Threshold in Trained Athletes
Daniel Gotti1, Giorgio Brambilla2, Andrea Meloni1
1Università degli Studi di Milano, Department of Biomedical Sciences for Health, Lombardy, Italy, Milan.
Abstract:
The aim of the present study was to evaluate the Record Power Output 1-12 test as a practical field-based estimate of anaerobic threshold markers in trained cyclists and to compare its association and agreement with established laboratory-based methods. Twenty-three trained male cyclists performed both a standard incremental ramp test with capillary blood lactate measurements and the Record Power Output 1-12 protocol, consisting of a 1-minute maximal effort followed by a 12-minute maximal effort. Threshold estimation was calculated using the formula RPO12-(5%×RPO1). The Record Power Output 1-12 test values were compared with established anaerobic threshold markers, including D max variants, onset of blood lactate accumulation thresholds, second lactate turn point, critical power and expert-determined second lactate threshold. Associations were evaluated using linear regression while agreement was assessed using Bland-Altman analysis. In addition, 90% confidence intervals derived from the two one-sided test were reported descriptively. The Record Power Output 1-12 test showed strong correlations with all investigated anaerobic threshold markers (r=0.87-0.99). However, Bland-Altman analyses revealed relatively wide limits of agreement across comparisons, consistent with previous literature, and mean differences were the largest with D max (- 28.12 W) and Exp-D max (- 18.98 W). Overall, the Record Power Output 1-12 test demonstrated strong correlations with commonly used threshold markers but limited interchangeability at the individual level, suggesting potential utility for field-based athlete monitoring when laboratory testing is not feasible.

